Search
Feed aggregator
Opinion: Prepare Your Biopharma for the Next Pandemic, for Business and Global Good
Opinion: Prepare Your Biopharma for the Next Pandemic, for Business and Global Good 6/26/2024
5 FDA Decisions to Watch in the Second Half of 2024
5 FDA Decisions to Watch in the Second Half of 2024 6/24/2024
FDA Action Alert: Merck, Verona, AbbVie and Rocket
FDA Action Alert: Merck, Verona, AbbVie and Rocket 6/24/2024
Expanded Approval of Sarepta’s Elevidys Is Progress, But More Needed for DMD Patients
Expanded Approval of Sarepta’s Elevidys Is Progress, But More Needed for DMD Patients 6/21/2024
Zealand Deepens Weight-Loss Portfolio With Strong Phase Ib Data for GLP-1 Alternative
Zealand Deepens Weight-Loss Portfolio With Strong Phase Ib Data for GLP-1 Alternative 6/21/2024
Jazz’s Tremor Drug Candidate Flops in Phase II Study, Misses Primary Endpoint
Jazz’s Tremor Drug Candidate Flops in Phase II Study, Misses Primary Endpoint 6/21/2024
Vertex Finally Reaches Pricing Deal with England’s NHS for Cystic Fibrosis Drug
Vertex Finally Reaches Pricing Deal with England’s NHS for Cystic Fibrosis Drug 6/21/2024
Vanda Turns Down Cycle, Future Pak Offers as Proposals ‘Undervalue’ Company
Vanda Turns Down Cycle, Future Pak Offers as Proposals ‘Undervalue’ Company 6/21/2024
Tectonic Completes Reverse Merger With Avrobio, Starts Trading on Nasdaq
Tectonic Completes Reverse Merger With Avrobio, Starts Trading on Nasdaq 6/21/2024
Sarepta Wins Full Approval and Label Expansion for DMD Gene Therapy
Sarepta Wins Full Approval and Label Expansion for DMD Gene Therapy 6/21/2024
Lilly Takes More Legal Actions Over Compounded Tirzepatide, Warns About Counterfeits
Lilly Takes More Legal Actions Over Compounded Tirzepatide, Warns About Counterfeits 6/20/2024
Gilead’s Twice-Yearly Shot Shows 100% Efficacy in Phase III HIV Prevention Trial in Women
Gilead’s Twice-Yearly Shot Shows 100% Efficacy in Phase III HIV Prevention Trial in Women 6/20/2024
PTC Reports Positive Phase II Huntington’s Data, FDA Lifts Partial Clinical Hold
PTC Reports Positive Phase II Huntington’s Data, FDA Lifts Partial Clinical Hold 6/20/2024
Challenging Research Models to Improve Health Equity
Challenging Research Models to Improve Health Equity 6/20/2024
Experimental Parkinson’s Treatment Elicits Antibodies Against Toxic Protein in Phase I
Experimental Parkinson’s Treatment Elicits Antibodies Against Toxic Protein in Phase I 6/20/2024
BioSpace at #DIA2024: Workforce Trends, Trial Design, Peter Marks & Recap
BioSpace at #DIA2024: Workforce Trends, Trial Design, Peter Marks & Recap 6/20/2024
Executives Share Top Tips for a Successful Career Journey
Executives Share Top Tips for a Successful Career Journey 6/20/2024
Better Collaboration: 7 Tips for Effective Workplace Communication
Better Collaboration: 7 Tips for Effective Workplace Communication 6/20/2024
FTC Supports PTO Push for Patent Settlement Scrutiny, Better Antitrust Oversight
FTC Supports PTO Push for Patent Settlement Scrutiny, Better Antitrust Oversight 6/20/2024
NIH Finds Non-Chemo Drug Combo Induces Lasting Remission in DLBCL Patients
NIH Finds Non-Chemo Drug Combo Induces Lasting Remission in DLBCL Patients 6/20/2024
World Pharma News
- U.S. FDA grants full approval to Pfizer's BRAFTOVI combination regimen in first-line metastatic colorectal cancer
- New antibody-drug conjugate strategy to block HIV infection
- Rhododendron-derived drugs now made by bacteria
- Lung cancer drug offers a surprising new treatment against ovarian cancer
- Researchers identify promising Alzheimer's disease drug target